scholarly journals Primary Pulmonary Lymphoma Presenting with Superior Vena Cava Syndrome in a Young Female

2017 ◽  
Vol 2017 ◽  
pp. 1-4
Author(s):  
Divya Salhan ◽  
Prakash Verma ◽  
Tun Win Naing ◽  
Ebad Ur Rehman ◽  
Saroj Kandel ◽  
...  

Primary Pulmonary Diffuse Large B Cell Lymphoma (PPDLBCL) is an extremely rare entity, which exhibits an aggressive behavior by compressing local blood vessels. It represents only 0.04% of all lymphoma cases and is extremely rare in young age. We present a case of a primary pulmonary lymphoma with superior vena cava syndrome (SVCS) in a young female. 27-year-old African American female presented with fever, cough, and facial puffiness for 2 weeks and unintentional weight loss. Chest examination showed decreased breath sounds and dullness on percussion on right side. Labs were normal except for mild leukocytosis, high lactate, and lactate dehydrogenase. Chest X-ray showed a large right side infiltrate with pleural effusion but chest CT showed 10 × 14 × 16 cm mass in the right lung without hilar and mediastinal lymphadenopathy. CT guided biopsy of the right lung mass was done and large B cell lymphoma was diagnosed. She received “involved field radiation” because of the bulky tumor size and superior vena cava involvement prior to R-CHOP to which she responded well. PPDLBCL should be considered as one of the differentials in a young patient with a large lung mass, which needs timely diagnosis and management.

2018 ◽  
Vol 1 (2) ◽  
pp. 131
Author(s):  
Alfian Nur Rosyid ◽  
Resti Yudhawati Meliana

Primary Pulmonary Lymphoma (PPL) is a clonal proliferation of lymphoid cells that involve one or two lungs (parenchyma and or bronchi. PPL is found in approximately 0.4% of all lymphoma cases and 3.6% of NHL cases. Five years survival rate at stage I and II is 90%, and 80% in stage III and IV. A 63-year-old male farmer presented with chief complaint of shortness of breath for one week before admission and preceded by coughing for a month, loss of appetite and night sweating. There was an abnormal physical examination on the right side of the chest with non-tender lymph node enlargements in the right supraclavicular and neck region and superior vena cava syndrome. CT guided FNAB suggesting NHL. Patient was treated with CHOP chemotherapy regiment. However, with high grade lymphoma, patient did not respond well.


2009 ◽  
Vol 25 (6) ◽  
pp. e210-e212 ◽  
Author(s):  
Amer Johri ◽  
Tara Baetz ◽  
Phillip A. Isotalo ◽  
Robert L. Nolan ◽  
Anthony J. Sanfilippo ◽  
...  

2017 ◽  
Vol 56 (15) ◽  
pp. 2043-2047 ◽  
Author(s):  
Shingen Nakamura ◽  
Kumiko Kagawa ◽  
Ryohei Sumitani ◽  
Munenori Uemura ◽  
Mamiko Takahashi ◽  
...  

2013 ◽  
Vol 24 ◽  
pp. e176-e177 ◽  
Author(s):  
L. Ruzickova ◽  
C. Canha ◽  
L. Geraldes ◽  
P. César ◽  
J. Carda ◽  
...  

2016 ◽  
Vol 2016 (4) ◽  
pp. rjw044
Author(s):  
Ashwad Afzal ◽  
Ivan Wong ◽  
Aleksandr Korniyenko ◽  
Alex Ivanov ◽  
Berhane Worku ◽  
...  

2002 ◽  
Vol 9 (5) ◽  
pp. 680-684 ◽  
Author(s):  
Matthias Martin ◽  
Iris Baumgartner ◽  
Martin Kolb ◽  
Jürgen Triller ◽  
Hans-Peter Dinkel

Purpose: To report a rare, fatal complication of superior vena cava Wallstent implantation. Case Report: A 59-year-old man presenting with superior vena cava syndrome caused by small-cell lung cancer underwent stent implantation of 2 kissing Wallstents >1.5 cm above the right atrium. Despite correct stent deployment, vessel perforation occurred in a section not encased by tumor, which led to fatal pericardial tamponade shortly after the procedure. Autopsy revealed perforation of a stent strut through the caval wall into the pericardial space. Anatomical and methodological reasons are discussed. Conclusions: The interventionist should be aware of this rare complication. Alternative stent designs avoiding the sharp ends of Wallstents and Palmaz stents should be considered.


Sign in / Sign up

Export Citation Format

Share Document